Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (61-70 of 156) with videos related to

Pageof 16
Sort By:
BJU International|January 25, 2006
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancerDavid G McLeod, Peter Iversen, William A See, et al.
Scandinavian Journal of Urology|July 6, 2012
Radical prostatectomy in clinically localized high-risk prostate cancer: outcome of 231 consecutive patientsMartin Andreas Røder, Kasper Drimer Berg, Ib Jarle Christensen, et al.
BJU International|December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 yearsPeter Iversen, David G McLeod, William A See, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 4, 2012
Is it possible to predict low-volume and insignificant prostate cancer by core needle biopsies?Kasper Drimer Berg, Birgitte Grønkaer Toft, Martin Andreas Røder, et al.
The Journal of Urology|November 16, 2004
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 yearsManfred P Wirth, William A See, David G McLeod, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma-18F-FDOPA vs Somatostatin AnaloguesAndreas Ebbehoj, Peter Iversen, Stine Kramer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2015
Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depressionThea P Lillethorup, Peter Iversen, Jesper Fontain, et al.
Advances in Experimental Medicine and Biology|March 30, 2011
Variable ATP yields and uncoupling of oxygen consumption in human brainAlbert Gjedde, Joel Aanerud, Ericka Peterson, et al.
Journal of Parkinson'S Disease|February 4, 2017
Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson's Disease: A Colon Transit and Volume StudyKaroline Knudsen, Tatyana D Fedorova, Anne C Bekker, et al.
Ugeskrift for Laeger|August 13, 2011
[Cryotherapy of prostatic cancer]Peter Iversen, Klaus Brasso, Jesper Rye Andersen, et al.
Pageof 16

Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
BJU International|January 25, 2006
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancerDavid G McLeod, Peter Iversen, William A See, et al.
Scandinavian Journal of Urology|July 6, 2012
Radical prostatectomy in clinically localized high-risk prostate cancer: outcome of 231 consecutive patientsMartin Andreas Røder, Kasper Drimer Berg, Ib Jarle Christensen, et al.
BJU International|December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 yearsPeter Iversen, David G McLeod, William A See, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 4, 2012
Is it possible to predict low-volume and insignificant prostate cancer by core needle biopsies?Kasper Drimer Berg, Birgitte Grønkaer Toft, Martin Andreas Røder, et al.
The Journal of Urology|November 16, 2004
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 yearsManfred P Wirth, William A See, David G McLeod, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma-18F-FDOPA vs Somatostatin AnaloguesAndreas Ebbehoj, Peter Iversen, Stine Kramer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2015
Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depressionThea P Lillethorup, Peter Iversen, Jesper Fontain, et al.
Advances in Experimental Medicine and Biology|March 30, 2011
Variable ATP yields and uncoupling of oxygen consumption in human brainAlbert Gjedde, Joel Aanerud, Ericka Peterson, et al.
Journal of Parkinson'S Disease|February 4, 2017
Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson's Disease: A Colon Transit and Volume StudyKaroline Knudsen, Tatyana D Fedorova, Anne C Bekker, et al.
Ugeskrift for Laeger|August 13, 2011
[Cryotherapy of prostatic cancer]Peter Iversen, Klaus Brasso, Jesper Rye Andersen, et al.
Pageof 16